Free Trial

MIRA Pharmaceuticals (MIRA) Competitors

MIRA Pharmaceuticals logo
$1.73 -0.01 (-0.57%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.74 +0.01 (+0.58%)
As of 07/25/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MIRA vs. ANIX, COYA, CRBP, HURA, MGNX, ZNTL, OPTN, WHWK, CTNM, and CLYM

Should you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include Anixa Biosciences (ANIX), Coya Therapeutics (COYA), Corbus Pharmaceuticals (CRBP), TuHURA Biosciences (HURA), MacroGenics (MGNX), Zentalis Pharmaceuticals (ZNTL), OptiNose (OPTN), Whitehawk Therapeutics (WHWK), Contineum Therapeutics (CTNM), and Climb Bio (CLYM). These companies are all part of the "pharmaceutical products" industry.

MIRA Pharmaceuticals vs. Its Competitors

Anixa Biosciences (NASDAQ:ANIX) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

Anixa Biosciences currently has a consensus price target of $9.00, suggesting a potential upside of 179.50%. MIRA Pharmaceuticals has a consensus price target of $14.00, suggesting a potential upside of 709.25%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe MIRA Pharmaceuticals is more favorable than Anixa Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anixa Biosciences
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
MIRA Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

29.1% of Anixa Biosciences shares are owned by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are owned by institutional investors. 25.3% of Anixa Biosciences shares are owned by company insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Anixa Biosciences had 4 more articles in the media than MIRA Pharmaceuticals. MarketBeat recorded 5 mentions for Anixa Biosciences and 1 mentions for MIRA Pharmaceuticals. MIRA Pharmaceuticals' average media sentiment score of 1.87 beat Anixa Biosciences' score of 1.27 indicating that MIRA Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Anixa Biosciences Positive
MIRA Pharmaceuticals Very Positive

Anixa Biosciences' return on equity of -68.17% beat MIRA Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Anixa BiosciencesN/A -68.17% -60.38%
MIRA Pharmaceuticals N/A -341.08%-272.93%

Anixa Biosciences is trading at a lower price-to-earnings ratio than MIRA Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anixa BiosciencesN/AN/A-$12.55M-$0.38-8.47
MIRA PharmaceuticalsN/AN/A-$7.85M-$0.51-3.39

Anixa Biosciences has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500.

Summary

MIRA Pharmaceuticals beats Anixa Biosciences on 7 of the 13 factors compared between the two stocks.

Get MIRA Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MIRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MIRA vs. The Competition

MetricMIRA PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$29.44M$3.07B$5.70B$9.50B
Dividend YieldN/A2.37%4.60%4.01%
P/E Ratio-3.3921.1828.1020.05
Price / SalesN/A286.99429.3789.38
Price / CashN/A42.7636.2258.56
Price / Book13.318.378.665.87
Net Income-$7.85M-$55.19M$3.25B$258.55M
7 Day Performance-3.89%5.88%4.22%3.73%
1 Month Performance42.98%17.33%10.51%11.75%
1 Year Performance-36.16%4.42%34.40%18.03%

MIRA Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MIRA
MIRA Pharmaceuticals
2.5933 of 5 stars
$1.73
-0.6%
$14.00
+709.2%
-43.1%$29.44MN/A-3.392Positive News
Gap Up
ANIX
Anixa Biosciences
3.0898 of 5 stars
$3.20
+1.9%
$9.00
+181.3%
+11.4%$103.07M$210K-8.425
COYA
Coya Therapeutics
1.9053 of 5 stars
$6.16
+0.5%
$16.50
+167.9%
-9.4%$103.03M$3.69M-5.766News Coverage
Analyst Forecast
CRBP
Corbus Pharmaceuticals
4.7901 of 5 stars
$8.36
+1.1%
$50.88
+508.6%
-83.3%$102.33MN/A-1.9840
HURA
TuHURA Biosciences
1.7792 of 5 stars
$2.33
+1.3%
$12.67
+443.6%
N/A$101.77MN/A0.00N/A
MGNX
MacroGenics
4.4323 of 5 stars
$1.58
-1.9%
$5.71
+261.7%
-68.9%$99.68M$152.43M-1.78430News Coverage
ZNTL
Zentalis Pharmaceuticals
2.3173 of 5 stars
$1.36
+2.3%
$8.37
+515.2%
-66.3%$97.85M$67.43M-0.43160News Coverage
OPTN
OptiNose
0.6383 of 5 stars
$9.60
flat
$9.00
-6.3%
N/A$97.22M$81.86M-2.29190
WHWK
Whitehawk Therapeutics
N/A$2.05
+7.3%
N/AN/A$96.57M$27.78M12.8140
CTNM
Contineum Therapeutics
3.3702 of 5 stars
$3.73
-4.8%
$22.50
+503.2%
-72.6%$96.50M$50M-1.8931
CLYM
Climb Bio
3.3682 of 5 stars
$1.42
+3.6%
$9.00
+533.8%
N/A$95.96MN/A-0.609

Related Companies and Tools


This page (NASDAQ:MIRA) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners